Lindbrook Capital’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-260
| Closed | -$910 | – | 2824 |
|
|
2024
Q3 | $910 | Sell |
260
-277
| -52% | -$970 | ﹤0.01% | 2521 |
|
|
2024
Q2 | $1.76K | Sell |
537
-252
| -32% | -$826 | ﹤0.01% | 2374 |
|
|
2024
Q1 | $5.79K | Buy |
789
+332
| +73% | +$2.44K | ﹤0.01% | 1835 |
|
|
2023
Q4 | $1.71K | Buy |
+457
| New | +$1.71K | ﹤0.01% | 2315 |
|
|
2023
Q2 | – | Sell |
-1,407
| Closed | -$8.02K | – | 2774 |
|
|
2023
Q1 | $8.02K | Buy |
1,407
+1,081
| +332% | +$6.16K | ﹤0.01% | 1594 |
|
|
2022
Q4 | $3.29K | Buy |
326
+119
| +57% | +$1.2K | ﹤0.01% | 2009 |
|
|
2022
Q3 | $5K | Sell |
207
-28
| -12% | -$676 | ﹤0.01% | 1662 |
|
|
2022
Q2 | $6K | Buy |
235
+45
| +24% | +$1.15K | ﹤0.01% | 1462 |
|
|
2022
Q1 | $7K | Sell |
190
-366
| -66% | -$13.5K | ﹤0.01% | 1441 |
|
|
2021
Q4 | $33K | Buy |
556
+520
| +1,444% | +$30.9K | 0.01% | 854 |
|
|
2021
Q3 | $2K | Hold |
36
| – | – | ﹤0.01% | 1527 |
|
|
2021
Q2 | $3K | Sell |
36
-33
| -48% | -$2.75K | ﹤0.01% | 1458 |
|
|
2021
Q1 | $6K | Buy |
69
+33
| +92% | +$2.87K | ﹤0.01% | 1202 |
|
|
2020
Q4 | $3K | Buy |
36
+24
| +200% | +$2K | ﹤0.01% | 1330 |
|
|
2020
Q3 | $0 | Sell |
12
-500
| -98% | – | ﹤0.01% | 1774 |
|
|
2020
Q2 | $18K | Buy |
512
+469
| +1,091% | +$16.5K | 0.01% | 643 |
|
|
2020
Q1 | $1K | Sell |
43
-1,957
| -98% | -$45.5K | ﹤0.01% | 1442 |
|
|
2019
Q4 | $39K | Buy |
+2,000
| New | +$39K | 0.01% | 518 |
|